The global Veterinary Infectious Disease Diagnostics Market is witnessing substantial growth as the need for rapid and accurate disease detection in animals continues to rise. According to a recent report, “Veterinary Infectious Disease Diagnostics Market by Product (Consumables, Instruments), Technology (Molecular Diagnostics, PCR, ELISA, Immunodiagnostics, Rapid Tests), Animal Type (Companion Animal, Livestock), End User & Region – Global Forecast to 2030,” the market is expected to grow from USD 2.87 billion in 2025 to USD 4.22 billion by 2030, registering a compound annual growth rate (CAGR) of 8.0% during the forecast period.
The increasing incidence of infectious diseases among companion and livestock animals, growing awareness of zoonotic disease transmission, and advancements in molecular diagnostic technologies are among the major factors driving market expansion.
Rising Animal Disease Burden Fuels Demand for Diagnostics
Infectious diseases remain a major challenge for animal health worldwide. Diseases affecting cattle, poultry, swine, and companion animals not only threaten animal welfare but also pose significant economic risks to livestock producers and public health systems.
The emergence and spread of zoonotic diseases—those transmitted between animals and humans—have intensified the need for effective surveillance and early detection. Veterinarians and animal health professionals are increasingly adopting advanced diagnostic solutions to identify pathogens quickly and implement timely treatment strategies.
In addition, the expanding global pet population and increased spending on pet healthcare are contributing to the growing demand for routine health screening and preventive diagnostics. Pet owners are becoming more proactive about ensuring the health and well-being of their animals, leading to increased adoption of sophisticated diagnostic technologies.
Technological Advancements Accelerating Market Growth
Technological innovation is transforming veterinary diagnostics by enabling faster, more accurate, and highly sensitive disease detection. Molecular diagnostic techniques, including polymerase chain reaction (PCR), real-time PCR (qPCR), and nucleic acid sequencing, have significantly improved the identification of bacterial, viral, and parasitic infections.
Compared with conventional methods, these technologies offer:
- Higher sensitivity and specificity
- Faster turnaround times
- Early-stage pathogen detection
- Improved treatment decisions
- Enhanced disease surveillance capabilities
The increasing availability of user-friendly diagnostic platforms and point-of-care testing solutions is further strengthening market growth, particularly in veterinary clinics and field settings.
Consumables Segment Dominated the Market in 2024
Based on product, the consumables segment accounted for the largest share of the veterinary infectious disease diagnostics market in 2024.
Diagnostic consumables, including test kits, reagents, assay cartridges, and other laboratory supplies, are essential components used in various testing procedures such as:
- PCR testing
- ELISA assays
- Lateral flow tests
- Immunodiagnostic procedures
- Molecular diagnostic applications
Unlike diagnostic instruments, which are generally purchased as one-time capital investments, consumables are used repeatedly with each test performed. This recurring usage pattern creates a continuous demand stream and significantly contributes to market revenues.
The growing volume of diagnostic testing across veterinary hospitals, reference laboratories, and point-of-care settings is expected to sustain the strong growth of this segment throughout the forecast period.
Molecular Diagnostics Expected to Register the Highest Growth Rate
Among technologies, the molecular diagnostics segment is projected to witness the highest CAGR between 2025 and 2030.
Molecular diagnostics has emerged as a preferred approach for detecting infectious agents due to its exceptional accuracy and ability to identify pathogens even at very low concentrations. Technologies such as PCR and real-time PCR are increasingly being used to diagnose complex and emerging infectious diseases in both companion animals and livestock.
Several factors are driving the rapid expansion of this segment:
- Rising prevalence of infectious diseases in animals
- Increasing need for early and precise diagnosis
- Growing adoption of advanced laboratory techniques
- Faster and more reliable test results
- Improved clinical decision-making capabilities
As veterinary healthcare providers seek more efficient and sensitive testing methods, molecular diagnostics is expected to become a cornerstone of modern veterinary disease management.
North America Led the Market in 2024
Geographically, North America accounted for the largest share of the veterinary infectious disease diagnostics market in 2024.
The region’s dominance can be attributed to several factors, including:
Strong Veterinary Healthcare Infrastructure
North America possesses a well-established network of veterinary hospitals, specialty clinics, and reference laboratories equipped with advanced diagnostic technologies.
High Pet Healthcare Expenditure
Pet owners in the United States and Canada are increasingly investing in preventive healthcare services and early disease detection. Rising disposable incomes and expanding pet insurance coverage further support market growth.
Presence of Major Industry Players
Many leading companies operating in veterinary diagnostics are headquartered in North America, facilitating continuous product innovation and market development.
Government Initiatives for Zoonotic Disease Control
Regulatory authorities and public health organizations are emphasizing surveillance programs and disease prevention measures to minimize the risk of zoonotic disease outbreaks, thereby driving demand for advanced diagnostic solutions.
Competitive Landscape
The veterinary infectious disease diagnostics market is characterized by the presence of several established players focused on innovation, product development, and strategic collaborations.
Prominent companies operating in the market include:
- IDEXX Laboratories, Inc. (US)
- Zoetis Services LLC (US)
- Thermo Fisher Scientific Inc. (US)
- Virbac (France)
- bioMérieux (France)
- Antech Diagnostics, Inc. (US)
- Innovative Diagnostics (France)
- Neogen Corporation (US)
- INDICAL BIOSCIENCE GmbH (Germany)
- Agrolabo S.p.A. (Italy)
These companies are investing heavily in molecular diagnostics, automated platforms, and rapid testing technologies to strengthen their market positions and address the growing need for effective animal disease management.
Outlook
The veterinary infectious disease diagnostics market is poised for robust growth through 2030, driven by increasing disease prevalence, heightened awareness regarding zoonotic infections, and continuous technological advancements. The rising emphasis on preventive veterinary care and early disease detection will further support the adoption of advanced diagnostic solutions across companion animal and livestock sectors.
As veterinary medicine continues to evolve, innovative diagnostic technologies will play an increasingly vital role in safeguarding animal health, ensuring food safety, and protecting public health worldwide.